Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | 2 | IFN-g | 18.5 | 62 | ||||
N2586 | IL-17A | 100 | ng/mL | 2 | IFN-g | 24.0 | 49 | ||||
N2586 | EO1428 | 1.0 | uM | IL-17A | 100 | ng/mL | 2 | IFN-g | 22.5 | 56 | |
N2586 | PI103 | 0.1 | uM | IL-17A | 100 | ng/mL | 2 | IFN-g | 17.0 | 50 | |
N2586 | Sigma A6730 | 3.0 | uM | IL-17A | 100 | ng/mL | 2 | IFN-g | 21.0 | 51 | |
N2586 | JNK-IN-8 | 3.0 | uM | IL-17A | 100 | ng/mL | 2 | IFN-g | 21.0 | 51 | |
N2586 | JNK-IN-11 | 0.3 | uM | IL-17A | 100 | ng/mL | 2 | IFN-g | 23.0 | 57 | |
N2586 | Tofacitinib | 0.3 | uM | 2 | IFN-g | 21.0 | 32 | ||||
RA2159 | 2 | IFN-g | 24.0 | 51 | |||||||
RA2159 | EO1428 | 1.0 | uM | 2 | IFN-g | 17.0 | 49 | ||||
RA2159 | PI103 | 0.1 | uM | 2 | IFN-g | 20.0 | 57 | ||||
RA2159 | Sigma A6730 | 3.0 | uM | 2 | IFN-g | 22.5 | 30 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 2 | IFN-g | 18.0 | 59 | ||||
RA2159 | JNK-IN-11 | 0.3 | uM | 2 | IFN-g | 18.0 | 53 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IFN-g | 21.5 | 48 | ||||
N2586 | 2 | IFN-g | 21.0 | 53 | |||||||
N2586 | EO1428 | 1.0 | uM | 2 | IFN-g | 18.0 | 47 | ||||
N2586 | PI103 | 0.1 | uM | 2 | IFN-g | 17.0 | 55 | ||||
N2586 | Sigma A6730 | 3.0 | uM | 2 | IFN-g | 19.0 | 60 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 2 | IFN-g | 20.5 | 52 | ||||
N2586 | JNK-IN-11 | 0.3 | uM | 2 | IFN-g | 19.5 | 40 | ||||
N2586 | IKK16 | 2.0 | uM | 2 | IFN-g | 20.5 | 44 | ||||
RA2159 | EGF | 100 | ng/mL | 2 | IFN-g | 20.0 | 69 | ||||
RA2159 | EO1428 | 1.0 | uM | EGF | 100 | ng/mL | 2 | IFN-g | 18.0 | 50 | |
RA2159 | PI103 | 0.1 | uM | EGF | 100 | ng/mL | 2 | IFN-g | 21.0 | 65 |